New drug may boost stem cell transplants for tough leukemia
Disease control
Not yet recruiting
This study tests a new approach for adults with relapsed or refractory acute myeloid leukemia (AML) who have active disease. It uses a radioactive drug (131I-apamistamab) combined with low-dose radiation and chemotherapy before a stem cell transplant. The goal is to see if this h…
Phase: PHASE2, PHASE3 • Sponsor: Actinium Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 07:02 UTC